Moalem Moshe has filed a Schedule 13D regarding his ownership stake in Nano-X Imaging Ltd., a company focused on X-ray apparatus and related technologies. This filing is significant as it highlights Moshe's dissatisfaction with the company's current performance and his intent to engage in discussions regarding its governance and strategy.

Nano-X Imaging Ltd. operates in the X-ray apparatus and tubes industry, as indicated by its SIC classification. The company is incorporated in L3 and has been publicly traded, with its shares listed under the ticker symbol not specified in the filing.

The filing reveals that Moshe owns 6,675,413 ordinary shares, representing 8.49% of the total shares outstanding. This ownership includes shares held directly and those held through Tanir Corporation BVI, a company he controls. Moshe's dissatisfaction stems from perceived issues with the company's performance, which he believes has negatively impacted shareholder value.

In his filing, Moshe explicitly opposes a proposed increase in the company's authorized share capital from 150 million to 450 million ordinary shares. He argues that such a move could lead to significant dilution for existing shareholders and questions the company's financing strategy given its recent performance. Moshe intends to vote against this proposal at the upcoming special general meeting scheduled for November 18, 2026.

Moreover, Moshe has expressed concerns about potential actions the company might take before the record date for the meeting. He aims to prevent any issuance of additional voting shares that could alter the voting dynamics and dilute shareholder influence. This situation may prompt other shareholders to take notice and potentially align with Moshe's stance.

As part of his ongoing engagement with Nano-X, Moshe may propose changes to the company's management and governance structure. He has reserved the right to make recommendations concerning the board's composition and may consider nominating candidates for election to the board. This could lead to a shift in how the company operates and interacts with its shareholders.

Details were not available in the SEC filing regarding any specific candidates Moshe may nominate or further actions he might take. However, his filing indicates a proactive approach to influencing the company's direction and ensuring that shareholder interests are prioritized.

In summary, Moshe's Schedule 13D filing marks a critical moment for Nano-X Imaging Ltd. and its shareholders. With the upcoming vote on the proposed share capital increase, the situation will be closely watched by industry observers and competitors alike.